AVXL
Price
$4.00
Change
-$0.13 (-3.15%)
Updated
Feb 5, 02:25 PM (EDT)
Capitalization
369.01M
4 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$0.16
Change
+$0.01 (+6.67%)
Updated
Feb 4 closing price
Capitalization
8.85M
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVXL vs QNCX

Header iconAVXL vs QNCX Comparison
Open Charts AVXL vs QNCXBanner chart's image
Anavex Life Sciences
Price$4.00
Change-$0.13 (-3.15%)
Volume$900
Capitalization369.01M
Quince Therapeutics
Price$0.16
Change+$0.01 (+6.67%)
Volume$5.15M
Capitalization8.85M
AVXL vs QNCX Comparison Chart in %
AVXL
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVXL vs. QNCX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Buy and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AVXL: $4.13 vs. QNCX: $0.16)
Brand notoriety: AVXL and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 132% vs. QNCX: 189%
Market capitalization -- AVXL: $369.01M vs. QNCX: $8.85M
AVXL [@Biotechnology] is valued at $369.01M. QNCX’s [@Biotechnology] market capitalization is $8.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 5 bullish, 5 bearish.
  • QNCX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than QNCX.

Price Growth

AVXL (@Biotechnology) experienced а -15.20% price change this week, while QNCX (@Biotechnology) price change was -95.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

AVXL is expected to report earnings on Feb 09, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($369M) has a higher market cap than QNCX($8.85M). AVXL YTD gains are higher at: 16.011 vs. QNCX (-95.257). QNCX (-44.18M) and AVXL (-46.38M) have comparable annual earnings (EBITDA) . AVXL has more cash in the bank: 103M vs. QNCX (26.3M). AVXL has less debt than QNCX: AVXL (88.2K) vs QNCX (18M). AVXL (0) and QNCX (0) have equivalent revenues.
AVXLQNCXAVXL / QNCX
Capitalization369M8.85M4,170%
EBITDA-46.38M-44.18M105%
Gain YTD16.011-95.257-17%
P/E RatioN/AN/A-
Revenue00-
Total Cash103M26.3M392%
Total Debt88.2K18M0%
FUNDAMENTALS RATINGS
AVXL vs QNCX: Fundamental Ratings
AVXL
QNCX
OUTLOOK RATING
1..100
1667
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6599
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVXL's Valuation (32) in the Biotechnology industry is in the same range as QNCX (47). This means that AVXL’s stock grew similarly to QNCX’s over the last 12 months.

AVXL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that AVXL’s stock grew similarly to QNCX’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as QNCX (100). This means that AVXL’s stock grew similarly to QNCX’s over the last 12 months.

AVXL's Price Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for QNCX (99). This means that AVXL’s stock grew somewhat faster than QNCX’s over the last 12 months.

AVXL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNCX (100). This means that AVXL’s stock grew similarly to QNCX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLQNCX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 24 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQICX21.130.31
+1.49%
Hartford Equity Income C
ACSYF0.83N/A
N/A
Accsys Technologies Plc.
VVIEX16.08-0.14
-0.86%
VOYA VACS Index Series EM Portfolio
IRLAX81.03-0.94
-1.15%
Voya Russell Large Cap Growth Idx Port A
CYBCF0.10N/A
-3.65%
Cybeats Technologies Corp.

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been closely correlated with QNCX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVXL jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-5.92%
QNCX - AVXL
68%
Closely correlated
+9.28%
MREO - AVXL
68%
Closely correlated
-2.73%
CALC - AVXL
62%
Loosely correlated
+8.37%
LEGN - AVXL
62%
Loosely correlated
-0.06%
CDXS - AVXL
61%
Loosely correlated
-2.94%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with MREO. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+9.28%
MREO - QNCX
86%
Closely correlated
-2.73%
CALC - QNCX
85%
Closely correlated
+8.37%
TPST - QNCX
84%
Closely correlated
-1.24%
RZLT - QNCX
83%
Closely correlated
-7.62%
GNTA - QNCX
83%
Closely correlated
-1.27%
More